Pegaspargase
Showing 26 - 50 of 149
Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Canada, Puerto Rico, United States (asparaginase, cyclophosphamide,
Completed
- Drug/Agent Toxicity by Tissue/Organ
- Leukemia
- asparaginase
- +15 more
-
Boston, Massachusetts
- +9 more
Nov 9, 2022
Extranodal NK/T-cell Lymphoma Trial (Basiliximab, Pegaspargase)
Unknown status
- Extranodal NK/T-cell Lymphoma
- Basiliximab
- Pegaspargase
- (no location specified)
Apr 6, 2020
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type Trial in Guangzhou (pegaspargase, Gemcitabine, Oxaliplatin)
Recruiting
- Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
- pegaspargase
- +5 more
-
Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat-sen University Cancer Ce
Mar 12, 2021
Lymphoma, Lymphoblastic Trial in GuangZhou (induction phase1, induction phase2, protocol M)
Unknown status
- Lymphoma, Lymphoblastic
- induction phase1
- +6 more
-
GuangZhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 31, 2020
Treatment Refusal Trial in Guangzhou (Gemcitabine, etoposide, Pegaspargase)
Unknown status
- Treatment Refusal
- Gemcitabine
- +3 more
-
Guangzhou, Please Select, ChinaSun Yat-sen University Cancer Center
Dec 16, 2020
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,
Recruiting
- Acute Lymphoblastic Leukemia
- Acute Lymphoblastic Lymphoma
- Prednisone
- +21 more
-
Palo Alto, California
- +6 more
May 2, 2022
T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)
Recruiting
- T Acute Lymphoblastic Leukemia
- T Lymphoblastic Lymphoma
- Cyclophosphamide
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Jan 11, 2023
Extranodal NK-T-Cell Lymphoma, Nasal Type Trial in Shanghai, Urumqi (MEDA, Auto-HSCT)
Completed
- Extranodal NK-T-Cell Lymphoma, Nasal Type
- MEDA
- Auto-HSCT
-
Shanghai, Shanghai, China
- +6 more
Apr 24, 2020
Leukemia, Acute Lymphoblastic Leukemia Trial in Houston (Rituximab, Cyclophosphamide (CTX), Doxorubicin)
Completed
- Leukemia
- Acute Lymphoblastic Leukemia
- Rituximab
- +11 more
-
Houston, TexasUT MD Anderson Cancer Center
Dec 1, 2020
NK/T Cell Lymphoma Nos Trial in Beijing (Sintilimab, Lenalidomide)
Unknown status
- NK/T Cell Lymphoma Nos
-
Beijing, ChinaBeijing Tongren Hospital
May 6, 2020
B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia Trial in Duarte (Cyclophosphamide, Cytarabine, Daunorubicin
Recruiting
- B Acute Lymphoblastic Leukemia
- Ph-Like Acute Lymphoblastic Leukemia
- Cyclophosphamide
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 26, 2022
Acute Lymphoblastic Leukemia Trial in Canada, United States (ITMHA, Dexamethasone, Mitoxantrone)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- ITMHA
- +13 more
-
Los Angeles, California
- +17 more
Jun 6, 2022
Leukemia, Lymphocytic, Lymphoblastic Lymphoma, T-cell Lymphoma Trial in United States (Palbociclib, Cytarabine, Methotrexate)
Active, not recruiting
- Leukemia, Lymphocytic
- +5 more
- Palbociclib
- +8 more
-
Birmingham, Alabama
- +18 more
Feb 25, 2022
Acute Lymphoblastic Leukemia Trial in GuangZhou (Cladribine, G-CSF, Cytarabine)
Unknown status
- Acute Lymphoblastic Leukemia
- Cladribine
- +3 more
-
GuangZhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 18, 2019
Lymphoma Trial in Changsha (pegaspargase, Gemcitabine, Oxaliplatin)
Unknown status
- Lymphoma
- pegaspargase
- +8 more
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Jan 25, 2020
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in Australia,
Completed
- Acute Lymphoblastic Leukemia
- +2 more
- Cyclophosphamide
- +12 more
-
Phoenix, Arizona
- +27 more
Apr 2, 2021
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Canada, United States (asparaginase Erwinia chrysanthemi)
Completed
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- asparaginase Erwinia chrysanthemi
-
Los Angeles, California
- +21 more
Jun 1, 2021
Acute Lymphoblastic Leukemia, Pediatric Trial in Worldwide (Blinatumomab, Bortezomib, Cyclophosphamide)
Recruiting
- Acute Lymphoblastic Leukemia, Pediatric
- Blinatumomab
- +18 more
-
Sydney, Australia
- +114 more
Nov 1, 2022
Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia
Recruiting
- Recurrent B Acute Lymphoblastic Leukemia
- +3 more
- Cyclophosphamide
- +9 more
-
Houston, TexasM D Anderson Cancer Center
Nov 2, 2022
Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia
Not yet recruiting
- Recurrent Acute Leukemia of Ambiguous Lineage
- +5 more
- Biospecimen Collection
- +12 more
- (no location specified)
Mar 8, 2023
B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Biospecimen Collection
- +19 more
- (no location specified)
Nov 8, 2023
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Down Syndrome Trial in Worldwide (drug, biological, radiation)
Recruiting
- B Acute Lymphoblastic Leukemia
- +2 more
- Asparaginase Erwinia chrysanthemi
- +15 more
-
Birmingham, Alabama
- +219 more
Aug 24, 2022
Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide
Active, not recruiting
- Acute Leukemia of Ambiguous Lineage
- +2 more
- Azacitidine
- +17 more
-
Birmingham, Alabama
- +173 more
Nov 16, 2021
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in United
Completed
- Acute Lymphoblastic Leukemia
- +2 more
- Calaspargase Pegol-mknl
- +14 more
-
Birmingham, Alabama
- +26 more
Apr 2, 2021